Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cyclophilin D (CypD), encoded by the PPIF gene, is a peptidyl-prolyl cis-trans isomerase located within the mitochondrial matrix (UniProt P30405). It serves as a key regulatory component of the mitochondrial permeability transition pore (mPTP), a high-conductance channel in the inner mitochondrial membrane (PubMed: 15744310). Under physiological conditions, CypD helps maintain mitochondrial function, but during pathological stress—such as oxidative stress or calcium overload—it triggers the opening of the mPTP. This opening leads to mitochondrial swelling, loss of membrane potential, and the release of pro-apoptotic factors, ultimately resulting in cell death via necrosis or apoptosis (PubMed: 15744311). Consequently, CypD is a significant therapeutic target for diseases characterized by mitochondrial dysfunction, including myocardial ischemia-reperfusion injury, stroke, and neurodegenerative conditions like Alzheimer's and Parkinson's diseases (PubMed: 25648232). Drugs like Cyclosporine A and its non-immunosuppressive analogs, such as Alisporivir, target CypD to prevent mPTP opening and protect cells from injury (PubMed: 21854169).
Inhibition of the peptidyl-prolyl isomerase activity of Cyclophilin D, which prevents its interaction with the mitochondrial permeability transition pore (mPTP) complex, thereby inhibiting pore opening and subsequent cell death (PubMed: 15744310).
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Peptidyl-prolyl cis-trans isomerase F, mitochondrial (Cyclophilin D) (CypD).